← Back to feedRead original →
VERIFIEDET Finance·positive
Gland Pharma inks strategic CDMO deal with global pharma firm, eyes $90-100 million annual revenue
AI Summary
- ·Gland Pharma has signed a strategic Manufacturing and Supply Agreement with a global pharmaceutical company for sterile injectable products.
- ·The deal encompasses 55 SKUs across three manufacturing sites.
- ·The agreement has an annualised revenue potential of $90-100 million, with revenue generation expected to commence in 2029.